Michael J. New reports for the National Review:
Earlier this month, more than 70 Democrats in the House introduced a resolution asking the Food and Drug Administration (FDA) to permanently lift in-person requirements for chemical-abortion drugs.
Over the past year and a half, supporters of legal abortion have used the COVID-19 pandemic to expand access to chemical abortion. In 2020, pro-abortion groups litigated against existing FDA rules, which had required that chemical abortions take place under medical supervision.